Metabolic profiling using combined GC–MS and LC–MS provides a systems understanding of aristolochic acid‐induced nephrotoxicity in rat

We present here a combined GC–MS and LC–MS metabolic profiling approach to unraveling the pathological outcomes of aristolochic acid (AA)‐induced nephrotoxicity. Urine samples were analyzed by GC–MS and LC–MS in combination with pattern recognition techniques, e.g. principal component analysis (PCA), orthogonal projection to latent structure‐discriminant analysis. The work indicates that AA‐induced acute renal toxicity as evidenced by histopathological examinations could be characterized by systemic disturbance of metabolic network involving free fatty acids generation, energy and amino acids metabolism, and alteration in the structure of gut microbiota. Therefore, this method is potentially applicable to the toxicological study, providing a comprehensive understanding of systems response to xenobiotic intervention.

[1]  R. Lin,et al.  Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells. , 2005, Kidney international.

[2]  I. Wilson,et al.  A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. , 2005, Journal of pharmaceutical and biomedical analysis.

[3]  C. Zoccali Biomarkers in chronic kidney disease: utility and issues towards better understanding , 2005, Current opinion in nephrology and hypertension.

[4]  R. Kini,et al.  Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. , 1987, Toxicon : official journal of the International Society on Toxinology.

[5]  M. Rantalainen,et al.  Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. , 2006, Journal of proteome research.

[6]  Jeremy K Nicholson,et al.  Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. , 2004, Chemical research in toxicology.

[7]  M. Jadoul,et al.  Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.

[8]  K. Clarke,et al.  A study of metabolic compartmentation in the rat heart and cardiac mitochondria using high‐resolution magic angle spinning 1H NMR spectroscopy , 2003, FEBS letters.

[9]  L. Hood,et al.  A data integration methodology for systems biology: experimental verification. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Mark R Viant,et al.  NMR-based metabolomics: a powerful approach for characterizing the effects of environmental stressors on organism health. , 2003, Environmental science & technology.

[11]  D. Denson,et al.  Contrasting effects of cPLA2 on epithelial Na+ transport. , 2001, American journal of physiology. Cell physiology.

[12]  Leroy Hood,et al.  The impact of systems approaches on biological problems in drug discovery , 2004, Nature Biotechnology.

[13]  Jeremy K Nicholson,et al.  NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. , 2003, Chemical research in toxicology.

[14]  D. Gauguier,et al.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.

[15]  J C Lindon,et al.  Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. , 1991, Molecular pharmacology.

[16]  A. Smilde,et al.  Fusion of mass spectrometry-based metabolomics data. , 2005, Analytical chemistry.

[17]  O. Fiehn,et al.  Metabolite profiling for plant functional genomics , 2000, Nature Biotechnology.

[18]  I. Wilson,et al.  A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. , 2006, Molecular bioSystems.

[19]  E. Lock,et al.  Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat. , 2005, Toxicology.

[20]  J. J. Moreno Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation. , 1993, Immunopharmacology.

[21]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[22]  V. Arlt,et al.  Aristolochic acid nephropathy and the peritoneum: Functional, structural, and molecular studies. , 2003, Kidney international.

[23]  M E Sullivan,et al.  Use of cultured cells of kidney origin to assess specific cytotoxic effects of nephrotoxins. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  Hai-yan Wang,et al.  Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[26]  V. Arlt,et al.  Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. , 2001, Kidney international.

[27]  M. Tanner,et al.  Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Sarda,et al.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells , 1995, Cell.

[29]  Galli Giovanni,et al.  Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects? , 2002, Journal of nephrology.

[30]  Y. Guiot,et al.  Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? , 2001, Kidney international.

[31]  B. Vishwanath,et al.  Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils. , 1989, Biochimica et biophysica acta.

[32]  Minjun Chen,et al.  Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. , 2007, Analytica chimica acta.

[33]  U. Mengs,et al.  Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology , 2005, Archives of Toxicology.

[34]  G. Deray,et al.  Herbs and the kidney. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  J. Van Camp,et al.  Creatine supplementation decreases homocysteine in an animal model of uremia. , 2003, Kidney international.

[36]  M. Rantalainen,et al.  The metabonomics of aging and development in the rat: an investigation into the effect of age on the profile of endogenous metabolites in the urine of male rats using 1H NMR and HPLC-TOF MS. , 2005, Molecular bioSystems.

[37]  V. Buckalew,et al.  Nephrolithiasis in renal tubular acidosis. , 1989, The Journal of urology.

[38]  Ping Liu,et al.  Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. , 2006, Journal of proteome research.

[39]  U. Mengs,et al.  Acute toxicity of aristolochic acid in rodents , 1987, Archives of Toxicology.